NCT03702231 2023-08-04Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)National Institutes of Health Clinical Center (CC)Phase 2 Completed116 enrolled 11 charts
NCT01798056 2021-05-13Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving ChemotherapyGlaxoSmithKlinePhase 3 Completed237 enrolled 20 charts
NCT02902822 2019-05-17Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of BergamoCentro Studi GisedPhase NA Completed461 enrolled
NCT01767467 2018-06-06Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood CancersGlaxoSmithKlinePhase 3 Completed568 enrolled 26 charts